Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PMS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | SMAD9 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
mRNA | AL513122.2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | AL513122.1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | MFSD10 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RNF168 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
mRNA | ITGB2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CDR2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |